Table 3.
Publication time | PMID | Author | Tumor type | Nonimmunogenic neoepitopes | Immunogenic neoepitopes | T-cell assay |
---|---|---|---|---|---|---|
2013-12 | 24323902 | D. A. Wick et al. | Ovarian cancer | — | 1 | ELISPOT |
2015-9 | 26359337 | E. M. Van Allen et al. | Melanoma | — | 18 | Clinical benefit |
2015-11 | 26752676 | T. Karasaki et al. | Lung adenocarcinoma | — | 4 | — |
2016-1 | 26901407 | A. Gros et al. | Melanoma | 12 | 14 | ELISPOT |
2016-5 | 27198675 | E. Strønen, et al. | Melanoma | 1134 | 16 | CTL clone |
2016-12 | 28405493 | A. Nelde et al. | Lymphoma | — | 2 | ELISPOT |
2017-6 | 28619968 | X. Zhang et al. | Breast cancer | — | 4 | Flow cytometry |
2017-10 | 29104575 | M. Markus et al. | Melanoma | 10 | 16 | — |
2017-11 | 29187854 | A.-M. Bjerregaard et al. | Polytype | 1874 | 42 | ELISPOT et al. |
2017-11 | 29132146 | V. P. Balachandran et al. | Pancreatic | — | 10 | Flow cytometry |
2018-5 | 29720506 | T. Matsuda et al. | Ovarian cancer | — | 3 | ELISPOT |
2018-12 | 29409514 | K. Sonntag et al. | Pancreatic ductal carcinoma | — | 3 | Flow cytometry |
2018-10 | 30357391 | V. Randi et al. | — | 6 | 35 | — |
Total | 3030 | 168 | ||||
Remove duplication | 2837 | 164 | ||||
Remove negative rank(%) > 2 and human 100% similar | 1697 | 164 |